May 11, 2017 - The following slide deck was published by AEGON NV in conjunction with their 2017 Q1 earnings call.
Sep 05, 2017 - The FDA approved the world's first CAR-T therapy on Wednesday, one month ahead of schedule, and only days after Gilead Sciences announced it’s buying CAR-T powerhouse Kite Pharma in a deal valued at $11.9 billion.
Sep 11, 2017 - Gilead Sciences CEO and oncology chief take on direct questions about why buying Kite was the right move.
Jan 27, 2018 - Right product, right price, right time. What more can you ask for?
Jul 17, 2018 - TomTom NV (OTCPK:TMOAF) Q2 2018 Earnings Conference Call July 17, 2018, 08:00 ET Executives Bruno Priuli - IR Harold Goddijn - Co-Founder, Chairman & CEO Taco Titulaer - CFO Analysts Francois Bouv
Apr 26, 2012 - QUAD GRAPHICS
Aug 26, 2015 - Novartis (NVS) with partner Ligand (LGND) announced that the FDA has approved the use of Promacta in children between 1 to 6 years of age with chronic ITP.
Sep 07, 2015 - Novartis' (NVS) Farydak (plus Velcade and dexamethasone) gets EU approval for relapsed and/or refractory multiple myeloma in treatment-experienced patients.
Sep 11, 2015 - Aduro (ADRO) signed a clinical study agreement with Incyte (INCY) to evaluate CRS-207, in combination with Incyte's epacadostat, in patients with ovarian cancer.
Sep 17, 2015 - Mylan NV (NASDAQ:MYL) Morgan Stanley Healthcare Conference Call September 17, 2015 2:40 PM ET Executives Heather Bresch - Chief Executive Officer John Sheehan - CFO, EVP, Principal Financial & Acc